Related Experiment Video
Updated: Jul 13, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Summary
Isotretinoin effectively treats severe cystic acne unresponsive to other treatments by reducing sebaceous gland size and sebum production. While generally safe, potential serious adverse effects necessitate its use for severe cases only.
Area of Science:
- Dermatology
- Pharmacology
Background:
- Acne vulgaris, particularly severe nodulocystic or conglobate forms, presents a therapeutic challenge.
- Existing treatments including antibiotics and topical agents often fail to achieve remission in severe cases.
Purpose of the Study:
- To review the chemistry, pharmacology, pharmacokinetics, clinical use, adverse effects, and FDA-approved indications of isotretinoin.
- To evaluate the efficacy and safety profile of isotretinoin for severe acne treatment.
Main Methods:
- Review of existing literature on isotretinoin.
- Analysis of clinical trial data regarding efficacy and adverse events.
- Pharmacokinetic and metabolic pathways of isotretinoin.
Main Results:
- Isotretinoin, a synthetic retinoid, reduces sebaceous gland size, inhibits sebum production, and decreases follicular keratinization, leading to effective treatment of severe acne.
- Clinical trials demonstrate significant efficacy in acne remission, even after treatment cessation.
- Common adverse effects are mucocutaneous (cheilitis, xerosis, dry nose), with rare serious events reported.
Conclusions:
- Isotretinoin is a highly effective treatment for severe, recalcitrant cystic acne.
- Due to cost and potential serious adverse effects, its use should be reserved for severe cases unresponsive to conventional therapies.
- Ongoing data collection is recommended to further assess long-term safety and efficacy.
Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...